Description

Amoxycillin Trihydrate 400 mg + Potassium Clavulanate 57 mg

High-Strength Protection Against Resistant Paediatric Infections
STOPBAC BID is a high-dose Amoxycillin-Clavulanate formulation specially developed for children requiring enhanced antibacterial coverage. It is recommended when standard amoxycillin therapy is inadequate or when resistance is suspected, delivering effective bacterial eradication with improved patient compliance through convenient twice-daily dosing.

Indications
✔️ Acute Otitis Media
✔️ Acute Bacterial Sinusitis
✔️ Community-Acquired Pneumonia
✔️ Upper Respiratory Tract Infections resistant to Amoxycillin monotherapy

STOPBAC BID — The trusted high-strength choice for faster recovery in children.